Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Lefvert

Showing results (81-90 of 181) with videos related to

Pageof 19
Sort By:
Clinical and Experimental Immunology|August 1, 1995
T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitisR Giscombe, J Grunewald, S Nityanand, et al.
Journal of Neuroimmunology|April 1, 1998
Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravisD Huang, R Pirskanen, P Hjelmström, et al.
Journal of Internal Medicine|August 22, 2006
Characterization of the expanded T-cell populations in patients with Wegener's granulomatosisR Giscombe, X B Wang, M Kakoulidou, et al.
Journal of Internal Medicine|December 20, 2007
Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravisX B Wang, R Pirskanen, R Giscombe, et al.
Clinical and Experimental Immunology|December 22, 1999
beta2-adrenergic receptor gene polymorphisms in myasthenia gravis (MG)B Y Xu, D Huang, R Pirskanen, et al.
Genes and Immunity|June 12, 2002
A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of proteinX B Wang, X Zhao, R Giscombe, et al.
Hybridoma|December 1, 1987
Isolation and characterization of autologous blood mononuclear cells used for auto-infusion together with monoclonal antibodies in tumor treatmentJ E Frödin, P Pihlstedt, A K Lefvert, et al.
Journal of Neuroimmunology|June 22, 1999
Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravisD R Huang, R Pirskanen, G Matell, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Properties and serum levels of specific populations of anti-acetylcholine receptor antibodies in myasthenia gravisB W Fulpius, A K Lefvert, S Cuénoud, et al.
Molecular Immunology|December 1, 1992
Human anti-acetylcholine receptor antibodies use variable gene segments analogous to those used in autoantibodies of various specificitiesK D Victor, V Pascual, A K Lefvert, et al.
Pageof 19

Showing results (81-90 of 181) with videos related to

Sort By:
Pageof 19
Clinical and Experimental Immunology|August 1, 1995
T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitisR Giscombe, J Grunewald, S Nityanand, et al.
Journal of Neuroimmunology|April 1, 1998
Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravisD Huang, R Pirskanen, P Hjelmström, et al.
Journal of Internal Medicine|August 22, 2006
Characterization of the expanded T-cell populations in patients with Wegener's granulomatosisR Giscombe, X B Wang, M Kakoulidou, et al.
Journal of Internal Medicine|December 20, 2007
Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravisX B Wang, R Pirskanen, R Giscombe, et al.
Clinical and Experimental Immunology|December 22, 1999
beta2-adrenergic receptor gene polymorphisms in myasthenia gravis (MG)B Y Xu, D Huang, R Pirskanen, et al.
Genes and Immunity|June 12, 2002
A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of proteinX B Wang, X Zhao, R Giscombe, et al.
Hybridoma|December 1, 1987
Isolation and characterization of autologous blood mononuclear cells used for auto-infusion together with monoclonal antibodies in tumor treatmentJ E Frödin, P Pihlstedt, A K Lefvert, et al.
Journal of Neuroimmunology|June 22, 1999
Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravisD R Huang, R Pirskanen, G Matell, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Properties and serum levels of specific populations of anti-acetylcholine receptor antibodies in myasthenia gravisB W Fulpius, A K Lefvert, S Cuénoud, et al.
Molecular Immunology|December 1, 1992
Human anti-acetylcholine receptor antibodies use variable gene segments analogous to those used in autoantibodies of various specificitiesK D Victor, V Pascual, A K Lefvert, et al.
Pageof 19